RecruitingPhase 3NCT04216186
Role of Coenzyme Q in ADHD in Children
Role of Coenzyme Q in Treatment of Attention Deficit Hyperactivity Disorder in Children
Sponsor
Sherief Abd-Elsalam
Enrollment
40 participants
Start Date
Nov 1, 2018
Study Type
INTERVENTIONAL
Conditions
Summary
Role of Coenzyme Q in ADHD in Children
Eligibility
Min Age: 2 YearsMax Age: 18 Years
Inclusion Criteria1
- Patients with ADHD
Exclusion Criteria1
- Comorbidities like Autism, Anxiety, Obsessive compulsive disorder.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGAtomoxetine
Atomoxetine once daily
DRUGCoenzyme Q
Coenzyme Q once daily
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04216186
Related Trials
Testing a Measurement Feedback App to Improve Data Quality, Supervision & Outcomes in Behavioral Health
NCT070423471 location
Five Digits Test - Validation of a Neuropsychological Test of Inhibition for Patients With Neuropsychiatric Conditions
NCT075319141 location
Spanish-language Executive Function Intervention for Children With Autism and/or ADHD
NCT070843241 location
Central Executive Training and Parent Training for ADHD
NCT054924221 location
Benefits of ADHD Treatment in Detained People
NCT058423301 location